The effectiveness of splint therapy in patients with temporomandibular disorders: A systematic review and meta-analysis
Author
dc.contributor.author
Ebrahim, Shanil
Author
dc.contributor.author
Montoya, Luis
Author
dc.contributor.author
Busse, Jason
Author
dc.contributor.author
Carrasco Labra, Alonso
Author
dc.contributor.author
Guyatt, Gordon H.
Admission date
dc.date.accessioned
2018-12-20T15:24:45Z
Available date
dc.date.available
2018-12-20T15:24:45Z
Publication date
dc.date.issued
2012
Cita de ítem
dc.identifier.citation
Journal of the American Dental Association, Volumen Volume 143, Issue 8, 2012, Pages 847-857.
Identifier
dc.identifier.issn
00028177
Identifier
dc.identifier.other
10.14219/jada.archive.2012.0289
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/159082
Abstract
dc.description.abstract
Purpose
The authors conducted a systematic review of all published randomized controlled trials in which investigators compared the effectiveness of splint therapy with that of minimal or no treatment in patients with temporomandibular disorders (TMDs).
Types of Studies Reviewed
The authors searched MEDLINE, Embase and the Cochrane Central Register of Controlled Trials for studies published from inception of each database through August 2011. In eligible studies, investigators enrolled adult patients with TMDs and assigned them randomly to splint therapy or a control group receiving minimal or no treatment.
Results
Of 1,567 potentially eligible studies, 11 proved eligible and were included. Moderate-quality evidence suggests that splint therapy reduced pain in the temporomandibular joint (TMJ) area (standardized response mean = −0.93, 95 percent confidence interval [CI], −1.33 to −0.53; risk difference for having continued pain = −0.35, 95 percent CI, −0.21 to −0.46; mean change on the 100-millimeter visual analog scale = −11.5 mm, 95 percent CI, −16.5 mm to −6.6 mm). Low to very low quality of evidence showed no significant differences between the splint therapy and control groups in terms of quality of life or depression. None of the trial reports described effect on function.
Conclusions
Although overall results are promising for the reduction of pain, establishing the role of splints for patients with TMDs will require large trials with stronger safeguards against bias.